HomeInsightsEPS

Suven Pharmaceuticals Ltd EPS

Suven Pharmaceuticals Ltd EPS

stocks purchased

₹ 2.0 Cr

Volume Transacted

(Jan 15, 2025)

stocks purchased

19.0 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Image

Suven Pharmaceuticals Ltd

NSE: SUVENPHAR

EPS

₹ 9.55

Last updated on: Jan 14, 2025

Key Highlights

  • The Earning per Share of Suven Pharmaceuticals Ltd is ₹ 9.55 as of 14 Jan 25 .
  • The earning per share of Suven Pharmaceuticals Ltd changed from ₹ 4.74 to ₹ 3.23 over 6 quarters. This represents a CAGR of -22.56% .

Historical Earning per Share of Suven Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Suven Pharmaceuticals Ltd

Market Cap

26,850 Cr

EPS

9.6

P/E Ratio (TTM) *

110.4

P/B Ratio (TTM) *

13.6

Day’s High *

1067.4

Day’s Low

1045.55

DTE *

0.0

ROE *

12.3

52 Week High

1359.0

52 Week Low

586.1

ROCE *

15.3

Market Price of Suven Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Suven Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251054.75
13 Jan 20251049.95
10 Jan 20251061.9
09 Jan 20251103.55
08 Jan 20251102.1
07 Jan 20251092.8
06 Jan 20251092.2
03 Jan 20251105.75
02 Jan 20251114.4
01 Jan 20251123.95

SWOT Analysis Of Suven Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Suven Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Suven Pharmaceuticals Ltd

Market Value

26,850

Asset Value

494

53.4 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Suven Pharmaceuticals Ltd926,850
Sun Pharmaceuticals Industries Ltd464,24,382
Divis Laboratories Ltd691,59,224
Cipla Ltd571,16,943
Dr Reddys Laboratories Ltd631,11,588
Mankind Pharma Ltd511,10,215

Historical Market Cap of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Suven Pharmaceuticals Ltd News Hub

News

Suven Pharmaceuticals schedules board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

28 Dec 2024 09:36

News

Suven Pharmaceuticals acquires 56% stake in NJ Bio Inc.

Suven Pharmaceuticals has acquired 56% equity share capital of NJ Bio, Inc. (target compan...

Read more

23 Dec 2024 11:34

News

Suven Pharmaceuticals strengths its ADC offering with acquisition of NJ Bio

Suven Pharmaceuticals announced the acquisition of a controlling stake in NJ Bio Inc. (NJ ...

Read more

07 Dec 2024 11:24

News

Suven Pharmaceuticals to acquire majority stake in US based NJ Bio

Suven Pharmaceuticals has executed definitive agreements today, i.e. 07 December 2024, for...

Read more

07 Dec 2024 11:20

News

Suven Pharma to acquire majority stake in US-based NJ Bio

The $64.4 million deal includes both primary equity infusion and secondary acquisition. As...

Read more

07 Dec 2024 17:20

News

Suven Pharmaceuticals Ltd Surges 4.23%

Suven Pharmaceuticals Ltd gained 4.23% today to trade at Rs 1359. The BSE Healthcare index...

Read more

02 Dec 2024 09:30

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

June 2024

TranscriptPPT

June 2023

TranscriptPPT

Feb 2023

Transcript

Dec 2022

Transcript

Nov 2022

Transcript

June 2022

Transcript

Feb 2022

PPT

Nov 2021

PPT

Aug 2021

PPT

June 2021

TranscriptPPT

FAQs for EPS of Suven Pharmaceuticals Ltd

What is the EPS of Suven Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Suven Pharmaceuticals Ltd is 9.55. An EPS is the amount of net income attributed to each share of a common stock.

How is Suven Pharmaceuticals Ltd EPS calculated?

The EPS of Suven Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Suven Pharmaceuticals Ltd report its EPS?

Suven Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Suven Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Suven Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Suven Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Suven Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions